Latest filings (excl ownership)
15-12G
Securities registration termination
14 Oct 22
25-NSE
Exchange delisting
4 Oct 22
8-K
Termination of a Material Definitive Agreement
3 Oct 22
POSASR
Automatic shelf registration (post-effective amendment)
3 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Oct 22
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
29 Sep 22
8-K
Regulation FD Disclosure
27 Sep 22
8-K
Regulation FD Disclosure
23 Sep 22
DEFA14A
Additional proxy soliciting materials
23 Sep 22
8-K
Other Events
23 Sep 22
UPLOAD
Letter from SEC
23 Sep 22
8-K
Other Events
19 Sep 22
424B7
Prospectus with selling stockholder info
19 Sep 22
8-K
Biohaven Announces Record Date for Anticipated Spin-Off
19 Sep 22
DEFM14A
Proxy related to merger
30 Aug 22
PRER14A
Preliminary revised proxy
24 Aug 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
8-K
Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments
5 Aug 22
PREM14A
Preliminary proxy related to merger
1 Jul 22
8-K
Other Events
28 Jun 22
DEFA14A
Additional proxy soliciting materials
16 May 22
DEFA14A
Additional proxy soliciting materials
11 May 22
DEFA14A
Additional proxy soliciting materials
11 May 22
8-K
Entry into a Material Definitive Agreement
10 May 22
DEFA14A
Additional proxy soliciting materials
10 May 22
DEFA14A
Additional proxy soliciting materials
10 May 22
DEFA14A
Additional proxy soliciting materials
10 May 22
DEFA14A
Additional proxy soliciting materials
10 May 22
10-Q
2022 Q1
Quarterly report
10 May 22
8-K
Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments
10 May 22
8-K
Pfizer to Acquire Biohaven Pharmaceuticals
10 May 22
8-K
Submission of Matters to a Vote of Security Holders
29 Apr 22
DEFA14A
Additional proxy soliciting materials
15 Apr 22
8-K
Departure of Directors or Certain Officers
15 Apr 22
8-K
Completion of Acquisition or Disposition of Assets
5 Apr 22
DEFA14A
Additional proxy soliciting materials
11 Mar 22
DEF 14A
Definitive proxy
11 Mar 22
Latest ownership filings
4
Biohaven Ltd.
5 Oct 22
4
James Engelhart
3 Oct 22
4
JOHN W CHILDS
3 Oct 22
4
Matthew Buten
3 Oct 22
4
Kishan Mehta
3 Oct 22
4
John Tilton
3 Oct 22
4
Vlad Coric
3 Oct 22
4
Michael Thomas Heffernan
3 Oct 22
4
JULIA P GREGORY
3 Oct 22
4
WILLIAM A JONES JR
3 Oct 22
4
ROBERT J HUGIN
3 Oct 22
4
Irina Antonijevic
3 Oct 22
4
George C. Clark
3 Oct 22
4
Gregory Bailey
3 Oct 22
4
Elyse Stock
3 Oct 22
4
Charles Conway
3 Oct 22
4
Kimberly Gentile
3 Oct 22
3
Biohaven Ltd.
28 Sep 22
4
Gregory Bailey
22 Aug 22
SC 13G/A
Capital World Investors
10 Jun 22
SC 13G/A
Capital International Investors
10 Jun 22
4
George C. Clark
12 May 22
4
Irina Antonijevic
12 May 22
3
Irina Antonijevic
11 May 22
SC 13G/A
Capital World Investors
10 May 22
4
Kishan Mehta
29 Apr 22
4
JULIA P GREGORY
29 Apr 22
4
JOHN W CHILDS
29 Apr 22
4
ROBERT J HUGIN
29 Apr 22
4
Gregory Bailey
29 Apr 22
4
Michael Thomas Heffernan
29 Apr 22
5
Declan Doogan
11 Feb 22
4/A
Declan Doogan
11 Feb 22
4/A
Declan Doogan
11 Feb 22
5
Vlad Coric
11 Feb 22
SC 13G/A
Capital World Investors
11 Feb 22
SC 13G/A
Capital International Investors
11 Feb 22
SC 13G/A
BlackRock Inc.
3 Feb 22
4
George C. Clark
24 Jan 22
4
George C. Clark
12 Jan 22